Anti-ARHGEF12 monoclonal antibody

Pre-made anti-ARHGEF12 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ARHGEF12/ARHGEF12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2353-Ab-1/ GM-Tg-hg-IP2353-Ab-2Anti-Human ARHGEF12 monoclonal antibodyHuman
GM-Tg-rg-IP2353-Ab-1/ GM-Tg-rg-IP2353-Ab-2Anti-Rat ARHGEF12 monoclonal antibodyRat
GM-Tg-mg-IP2353-Ab-1/ GM-Tg-mg-IP2353-Ab-2Anti-Mouse ARHGEF12 monoclonal antibodyMouse
GM-Tg-cynog-IP2353-Ab-1/ GM-Tg-cynog-IP2353-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGEF12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2353-Ab-1/ GM-Tg-felg-IP2353-Ab-2Anti-Feline ARHGEF12 monoclonal antibodyFeline
GM-Tg-cang-IP2353-Ab-1/ GM-Tg-cang-IP2353-Ab-2Anti-Canine ARHGEF12 monoclonal antibodyCanine
GM-Tg-bovg-IP2353-Ab-1/ GM-Tg-bovg-IP2353-Ab-2Anti-Bovine ARHGEF12 monoclonal antibodyBovine
GM-Tg-equg-IP2353-Ab-1/ GM-Tg-equg-IP2353-Ab-2Anti-Equine ARHGEF12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2353-Ab-1/ GM-Tg-hg-IP2353-Ab-2; GM-Tg-rg-IP2353-Ab-1/ GM-Tg-rg-IP2353-Ab-2;
GM-Tg-mg-IP2353-Ab-1/ GM-Tg-mg-IP2353-Ab-2; GM-Tg-cynog-IP2353-Ab-1/ GM-Tg-cynog-IP2353-Ab-2;
GM-Tg-felg-IP2353-Ab-1/ GM-Tg-felg-IP2353-Ab-2; GM-Tg-cang-IP2353-Ab-1/ GM-Tg-cang-IP2353-Ab-2;
GM-Tg-bovg-IP2353-Ab-1/ GM-Tg-bovg-IP2353-Ab-2; GM-Tg-equg-IP2353-Ab-1/ GM-Tg-equg-IP2353-Ab-2
Products NameAnti-ARHGEF12 monoclonal antibody
Formatmab
Target NameARHGEF12
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ARHGEF12 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2353-Ag-1Recombinant multi-species ARHGC/ ARHGEF12/ LARG protein


    Target information

    Target IDGM-IP2353
    Target NameARHGEF12
    Gene ID23365,69632,367072,712096,479409,101085657,503575,100071503
    Gene Symbol and Synonyms2310014B11Rik,ARHGEF12,LARG,mKIAA0382,PRO2792
    Uniprot AccessionQ9NZN5
    Uniprot Entry NameARHGC_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000196914
    Target ClassificationTumor-associated antigen (TAA)

    The target: ARHGEF12, gene name: ARHGEF12, also named as LARG, PRO2792. Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli working through G protein-coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein has been observed to form a myeloid/lymphoid fusion partner in acute myeloid leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.